References

  1. UNAIDS. UNAIDS Report. 2006. UNAIDS. Geneva.

  2. Federal Ministry of Health. National Guildlines for Paediatric HIV and AIDS treatment and care. 2007. Federal Ministry of Health. Abuja.

  3. UNAIDS. Report on the global AIDS epidemic. UNAIDS. 2008. Geneva.

  4. Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and Clinical associations of genotypes. Hepatol Res. 2007; 37: S9-S19. PubMed | Google Scholar

  5. Ejele OA, Ojule AC. The prevalence of hepatitis B surface antigen (HBsAg) among prospective blood donors and patients in Port Harcourt, Nigeria. Niger J Med. 2004;13: 336- 38. PubMed | Google Scholar

  6. Adoga MP, Gyar SD, Pechulano S, Bashayi OD et al. Hepatitis B virus infections in apparently healthy urban Nigerians: Data from pre-vaccination tests. J Infect Dev Ctries. 2010;30:397-400. PubMed | Google Scholar

  7. Aganga-Williams OM, Akanmu AS, Akinsete I. Prevalence of hepatitis B surface antigen among women of child-bearing age in Lagos State. Afr J of Rep Hlth.1999; 3: 45-50. PubMed | Google Scholar

  8. Alikor EA, Erhabor ON. Seroprevalence of hepatitis B surface antigenaemia in children in a tertiary health institution in the Niger Delta of Nigeria. Niger J Med. 2007;16:250-1. PubMed | Google Scholar

  9. Shepard CW, Finelli L, Fiore AE, Bell BP. Epidemiology of hepatitis B and hepatitis B virus infection in United States children. Pediatr Infect Dis J. 2005 ;24:755-60. PubMed | Google Scholar

  10. Mathews G, Bhagani S. The epidemiology and natural history of HIV/HBV and HIV/HCV co-infections. J HIV Ther. 2003 ;8:77-84. PubMed | Google Scholar

  11. Telatela SP, Matee MI, Munubhi EK. Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania. BMC Public Health. 2007;22:338. PubMed | Google Scholar

  12. Rana C, Gareth R, Dimitra B, Alexandra M, Jedediah R et al. Viral co-infection among Children Infected with HIV Type 1. Clin Infect Dis. 2003;36:922-24. PubMed | Google Scholar

  13. Zhou S, Zhao Y, He Y, Li H, Bulterys M, Sun X et al. Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009. J Acquir Immune Defic Syndr. 2010 ;54:191-6. PubMed | Google Scholar

  14. Ashir GM, Rabasa AI, Gofama MM, Bukbuk D, Abubakar H, Farouk GA. Study of hepatic functions and prevalence of hepatitis B surface antigenaemia in Nigerian children with human immunodeficiency virus infection. Niger J Med. 2009 ;18:260-2. PubMed | Google Scholar

  15. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis. 2009 ;200:39-47. PubMed | Google Scholar

  16. Wolters LM, Niesters HG, Hansen BE et al. Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort. J Clin Virol. 2002;24:173-81. PubMed | Google Scholar

  17. Rouet F, Chaix ML, Inwoley A, Anaky MF, Fassinou P et al. Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children. Clin Infect Dis. 2008; 46:361-6. PubMed | Google Scholar

  18. Guan R. Treatment of chronic hepatitis B in HIV co-infected patients. Med J Malaysia. 2005; 60 Suppl B:52-6. PubMed | Google Scholar

  19. Sulkowski.MS. Viral hepatitis and HIV coinfection. J Hepatol. 2008;48:353-67. PubMed | Google Scholar

  20. Levy V, Grant RM. Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls. Clin Infect Dis. 2006 ;43:904-10. PubMed | Google Scholar

  21. Iser DM, Sasadeusz JJ. Current treatment of HIV/hepatitis B virus coinfection. J Gastroenterol Hepatol. 2008 ;23:699-706. PubMed | Google Scholar

  22. Kumar R, Singla V, Kacharya S. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients. Trop Gastroenterol. 2008;29:136-47. PubMed | Google Scholar

  23. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat. 2009 ;16:94-103.. PubMed | Google Scholar